The Pulmonary Drug Delivery Systems Market is estimated to be valued at US$ 34.34 Bn in 2023 and is expected to exhibit a CAGR of 4.6% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Pulmonary drug delivery systems are treatment methods that deliver drugs directly into the lungs to treat various respiratory diseases including asthma, chronic obstructive pulmonary disease (COPD), and cystic ... Read more
